Street Drug Alternatives
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 3, 2000
January 26, 2021
345344ca-6b85-4f50-ab26-676bbb4cc144
Related Documents
Clinical Development Programs for Drugs, Devices, and Biological Products for the Treatment of Rheumatoid Arthritis (RA)
Guidance DocumentFebruary 17, 1999Center for Drug Evaluation and Research
Labeling OTC Human Drug Products Using a Column Format
Guidance DocumentDecember 19, 2000Center for Drug Evaluation and Research
Drug Master Files for Bulk Antibiotic Drug Substances: Guidance for Industry
Guidance DocumentNovember 29, 1999Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.